On July 30, 2026, the highest legal forums addressed a long-standing medical negligence complaint involving the tragic death of 57-year-old Purunananda Mukhopadhyay. Presided over by Justice A.P. Sahi, the legal proceedings center on allegations of severe medical mismanagement by Belle Vue Clinic and Dr. Manoj Agarwal. According to official reports, the patient suffered from persistent respiratory issues that ultimately proved to be lung cancer.
Official documents show that the patient was admitted to Belle Vue Clinic for a prolonged period of 42 days. The primary grievance outlined in the complaint states that attending medical staff failed to diagnose the underlying malignancy despite clear respiratory symptoms. Furthermore, the family alleges that necessary diagnostic tests required to confirm the presence of lung cancer were neither performed promptly nor adequately during this extended hospital stay.
As the patient’s condition worsened, family members transferred him to the R.N. Tagore International Institute of Cardiac Sciences (RNTIICS) for advanced medical intervention. Medical records indicate that physicians at the secondary facility performed a surgical procedure on September 8, 2012, led by Dr. Amitava Chakraborty. Despite intensive efforts by the surgical and critical care teams, the advanced stage of the carcinoma proved fatal, and the patient passed away on September 14, 2012.
This high-profile medical malpractice case highlights ongoing concerns regarding diagnostic accuracy and accountability within private healthcare institutions. Legal experts note that delayed diagnoses in oncology cases significantly diminish survival rates, putting immense emotional and financial strain on affected families. Industry analysts suggest that rulings from this case could establish critical precedents regarding hospital liability and the timely execution of diagnostic protocols.
Legal observers will closely monitor subsequent hearings to determine the extent of liability assigned to the hospital and the attending physicians. The tribunal’s final verdict is expected to shape future litigation standards concerning institutional accountability in complex medical misdiagnosis claims. Healthcare providers nationwide are reviewing internal protocols to prevent similar oversight regarding pulmonary evaluations.
Disclaimer: This article is published for general news and informational purposes only. While every effort has been made to ensure accuracy, readers are advised to verify important information from official sources. The publisher shall not be responsible for any loss or inconvenience arising from reliance on the information published.
